ArticleExperimental hematology & oncology2025

Tetrahydromagnolol targets TRIM38 to mediate PANoptosis in cancer cells and has the potential for synergistic cancer therapy.

Xiaoqing Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.